Differential regulation of striatal dopamine D1 and D2 receptors in acute and chronic parkinsonian monkeys

Brain Research

Volumn 847, Issue 1, 1999, Pages 134-138

  Decamp, E ^a   Wade, T ^a   Schneider, J S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Dopamine; Monkey; MPTP; Receptor; Striatum

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; SPIPERONE;

ANIMAL MODEL; ANIMAL TISSUE; AUTORADIOGRAPHY; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE DURATION; MONKEY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RECEPTOR DENSITY; SHORT SURVEY;

EID: 0032749901     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02015-6     Document Type: Article

References (21)

1. Alexander G.M., Brainard D.L., Gordon S.W., Hichens M., Grothusen J.R., Schwartzman R.J. Dopamine receptor changes in untreated and (+)-PHNO-treated MPTP parkinsonian primates. Brain Res. 547:1991;181-189.
2. Alexander G.M., Schwartzman R.J., Grothusen J.R., Brainard L., Gordon S.W. Changes in brain dopamine receptors in MPTP parkinsonian monkeys following L-dopa treatment. Brain Res. 588:1993;276-282.
3. 2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann. Neurol. 31:1992;184-192.
4. 2 receptor imaging with SPECT: studies in different neuropsychiatric disorders. J. Cereb. Blood Flow Metab. 11:1991;220-228.
5. 2 sites in parkinson syndrome of different etiology. Brain Res. 483:1989;30-38.
6. 2 dopamine receptor density in the MPTP monkeys. Neurosci. Lett. 86:1988;225-229.
7. Gagnon C., Bedard P.J., Di Paolo T. Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists. Eur. J. Pharmacol. 178:1988;115-120.
8. Gnanalingham K.K., Smith L.A., Hunter A.J., Jenner P., Marsden C.D. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study. Synapse. 14:1993;184-194.
9. 1 receptor supersensitivity: II. Unilateral intra-carotid infusion of MPTP in the monkey. Brain Res. 514:1990;103-110.
10. 2 receptors in the monkey brain in MPTP-induced parkinsonism. Brain Res. 602:1993;290-303.
11. Jenner P., Rupniak N.M.J., Rose S., Kelly E., Kilpatrick G., Lees A., Marsden C.D. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset. Neurosci. Lett. 50:1984;85-90.
12. Joyce J.N., Marshall J.F., Bankiewicz K.S., Kopin I.J., Jacobowitz D.M. Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D-2 receptor density. Brain Res. 382:1985;360-364.
13. 1 binding density following mesotelencephalic 6-hydroxydopamine injections: an autoradiographic analysis. Brain Res. 493:1989;247-257.
14. 2 receptor agonists. J. Neurochem. 72:1999;682-692.
15. 2 antagonists. Neuroscience. 25:1988;525-532.
16. 2 dopamine receptors. Mol. Brain Res. 12:1992;111-119.
17. Rinne J.O., Laihinen A., Lonnberg P., Marjamaki P., Rinne U.K. A postmortem study on striatal dopamine receptors in Parkinson's disease. Brain Res. 556:1991;117-122.
18. Rioux L., Frohna P.A., Joyce J.N., Schneider J.S. The effects of chronic levodopa treatment on pre- and post-synaptic markers of dopaminergic function in striatum of parkinsonian monkeys. Movement Disord. 12:1997;148-158.
19. Schneider J.S., Decamp E., Wade T. Striatal preproenkephalin gene expression is up-regulated in acute but not chronic parkinsonian monkeys: implications for the contribution of the indirect striatopallidal circuit to parkinsonian symptomatology. J. Neurosci. 19:1999;6643-6649.
20. Schneider J.S., Pope-Coleman A., Van Velson M., Menzaghi F., Lloyd G.K. Effects of SIB-1508Y, a novel neuronal nicotinic acetylcholine receptor agonist, on motor behavior in parkinsonian monkeys. Movement Disord. 13:1998;637-642.
21. 2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's and Huntington's diseases. Neuropsychopharmacology. 1:1987;5-15.